Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antipsychotic dose reduction: unclear benefits but certain risks.
Leucht S, Bighelli I, Siafis S, Schneider-Thoma J, Davis JM. Leucht S, et al. Lancet Psychiatry. 2023 Nov;10(11):819-821. doi: 10.1016/S2215-0366(23)00308-5. Epub 2023 Sep 28. Lancet Psychiatry. 2023. PMID: 37778354 No abstract available.
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies.
Siafis S, McCutcheon R, Chiocchia V, Ostinelli EG, Wright S, Stansfield C, Juma DO, Mantas I, Howes OD, Rutigliano G, Ramage F, Tinsdeall F, Friedrich C, Milligan L, Moreno C, Elliott JH, Thomas J, Macleod MR, Sena ES, Seedat S, Salanti G, Potts J, Cipriani A, Leucht S; GALENOS team. Siafis S, et al. Among authors: leucht s. Wellcome Open Res. 2023 Aug 25;8:365. doi: 10.12688/wellcomeopenres.19866.1. eCollection 2023. Wellcome Open Res. 2023. PMID: 38634067 Free PMC article.
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.
Campana M, Yakimov V, Moussiopoulou J, Maurus I, Löhrs L, Raabe F, Jäger I, Mortazavi M, Benros ME, Jeppesen R, Meyer Zu Hörste G, Heming M, Giné-Servén E, Labad J, Boix E, Lennox B, Yeeles K, Steiner J, Meyer-Lotz G, Dobrowolny H, Malchow B, Hansen N, Falkai P, Siafis S, Leucht S, Halstead S, Warren N, Siskind D, Strube W, Hasan A, Wagner E. Campana M, et al. Among authors: leucht s. Brain Behav Immun. 2024 Apr 10;119:353-362. doi: 10.1016/j.bbi.2024.04.011. Online ahead of print. Brain Behav Immun. 2024. PMID: 38608742 Free article.
The Placebo Effect in Psychosis: Why It Matters and How to Measure It.
Hird EJ, Diederen K, Leucht S, Jensen KB, McGuire P. Hird EJ, et al. Among authors: leucht s. Biol Psychiatry Glob Open Sci. 2023 Mar 5;3(4):605-613. doi: 10.1016/j.bpsgos.2023.02.008. eCollection 2023 Oct. Biol Psychiatry Glob Open Sci. 2023. PMID: 37881581 Free PMC article. Review.
Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development.
Pillinger T, Howes OD, Correll CU, Leucht S, Huhn M, Schneider-Thoma J, Gaughran F, Jauhar S, McGuire PK, Taylor DM, Young AH, McCutcheon RA. Pillinger T, et al. Among authors: leucht s. Lancet Psychiatry. 2023 Nov;10(11):860-876. doi: 10.1016/S2215-0366(23)00262-6. Epub 2023 Sep 26. Lancet Psychiatry. 2023. PMID: 37774723 Free PMC article.
491 results